The enlarged prostate body presses against the bladder and urethra. With each urination, it is continuously impacted by urine and squeezed and restricted by the urethral sphincter and pelvic muscles, which will lead to rupture of blood vessels in the prostate and hematuria.
The etiology of hematuria caused by BPH Many patients with BPH have clinical manifestations of hematuria. What is this?
Causes of hematuria caused by prostatic hyperplasia
1. The blood vessels in the hyperplastic prostate can also increase, especially a kind of hyperplasia that is pathologically classified as interstitial type, which is characterized by a large amount of hyperplasia of fibrous tissue and blood vessels. The hyperplastic tissue also protrudes into the urethral cavity, and the chances of being impacted by urine are many and strong. Because the hyperplastic prostate makes the patient's urination not smooth, the patient's urination force is too large, or the local sudden decompression after urination can easily lead to the rupture of rich blood vessels in the hyperplastic prostate, causing hematuria.
2. In addition, the pressure of prostatic hyperplasia on the urethra can also be combined with other diseases of the urinary tract, such as inflammation of the urethra and bladder, bladder stones, bladder diverticulum, etc. These diseases can also cause hematuria.
3. Generally speaking, most of the hematuria caused by BPH is not serious, and can stop without drugs. If other reasons such as tumor are excluded through relevant examination, don't worry too much.
4. The most fundamental treatment for bleeding caused by BPH is to cure BPH. In addition, it is also necessary to avoid excessive force during urination. Some data confirmed that about 15% and 1% of the patients were diagnosed as BPH due to hematuria, so it can be seen that hematuria in elderly men is often an early signal of BPH.
The most common cause of hematuria is benign diseases, such as cystitis, urinary calculus and tuberculosis. Of course, we should also pay special attention to urinary system tumors.
(Intern editor: Cai Junyi)